Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02268305 · ClinicalTrials.gov registry record · Phase 3
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
A Phase 3 study of Low Back Pain, sponsored by Mike O'Callaghan Military Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02268305: Completed Phase 3 study of Low Back Pain, sponsored by Mike O'Callaghan Military Hospital.
NCT02268305 is a Phase 3 study of Low Back Pain that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 100 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02268305, a Phase 3 study of Low Back Pain, has completed, sponsored by Mike O'Callaghan Military Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are studying whether MSM plus standard of care naproxen improves symptoms of lower back pain compared to standard of care naproxen plus placebo. Subjects will be randomized into 1 of 2 groups. Group 1 will take by mouth 6000 milligrams (mgs) of MSM plus standard of care naproxen. Group 2 will take by mouth placebo capsules plus standard of care naproxen. Subjects will be instructed to take their study pills for 12 weeks and record on a study diary. They will then be followed up for one final visit 4 weeks later. RMDQ, PIQ-6, pain level, comprehensive metabolic panel (CMP), complete blood count (CBC) will be assessed at 4 week intervals for 12 weeks. Subjects' participation will last 16 weeks.
Primary Outcome
decrease in pain via analogue pain scale of 0-10 (with 10 being the worst pain)
Conditions Studied
Interventions
- DRUG MSM 1000mg twice a day (6000 mgs)
- OTHER Placebo capsules twice a day
Study Locations (1)
Nevada
- Mike O'Callaghan Federal Medical Center - Nellis Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-02 |
| Est. Completion | 2018-06-05 |
| Phase | Phase 3 |
What the finished NCT02268305 record still lists
NCT02268305 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which MSM 1000mg twice a day (6000 mgs) is the first listed.
NCT02268305 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT02268305 about?
NCT02268305 is a clinical study titled "The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain". The investigators are studying whether MSM plus standard of care naproxen improves symptoms of lower back pain compared to standard of care naproxen plus placebo. Subjects will be randomized into 1 of 2 groups. Group 1 will take by mouth 6000 milligrams (mgs) of MSM plus standard of care naproxen. G...
What is the current status of trial NCT02268305?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2015-02. Estimated completion is 2018-06-05.
What conditions does trial NCT02268305 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT02268305?
The interventions under investigation include: MSM 1000mg twice a day (6000 mgs) (DRUG), Placebo capsules twice a day (OTHER).
Who is sponsoring clinical trial NCT02268305?
This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02268305 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02268305's enrollment target sits among peer trials
100 57th of 122 higher than 63 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
RECRUITING · Phase 3
-
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
COMPLETED · Phase 3
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
COMPLETED · Phase 3
-
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
COMPLETED · Phase 3
-
Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial
COMPLETED · Phase 3
-
Acupuncture Analgesia in Relation to Psychiatric Comorbidity
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia